Turn Therapeutics Inc.
TTRX
$5.25
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -784.50K | -784.50K | -494.80K | -494.80K | -389.40K |
| Total Depreciation and Amortization | 12.50K | 12.50K | 12.20K | 12.20K | 11.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 187.30K | 187.30K | 148.50K | 148.50K | 32.30K |
| Change in Net Operating Assets | 185.70K | 185.70K | -69.30K | -69.30K | 68.40K |
| Cash from Operations | -399.00K | -399.00K | -403.40K | -403.40K | -277.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.90K | -15.90K | -25.60K | -25.60K | -24.10K |
| Cash from Investing | -15.90K | -15.90K | -25.60K | -25.60K | -24.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.57M | 1.57M | 422.80K | 422.80K | 153.40K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.57M | 1.57M | 422.80K | 422.80K | 153.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.16M | 1.16M | -6.20K | -6.20K | -148.00K |